Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_1
1
11%
Ph phase_3
1
11%
Ph phase_2
3
33%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(2)
Other(2)

Detailed Status

Recruiting4
unknown2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

unknown222%
recruiting444%
completed222%
not_yet_recruiting111%

Recent Activity

4 active trials
Showing 5 of 9
recruitingphase_2

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

NCT07195734
recruitingphase_1

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

NCT04754321
not_yet_recruitingphase_2

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

NCT06987123
unknown

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

NCT06114420
recruitingnot_applicable

The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.

NCT05749887
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07195734Phase 2

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Recruiting
NCT04754321Phase 1

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Recruiting
NCT06987123Phase 2

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Not Yet Recruiting
NCT06114420

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Unknown
NCT05749887Not Applicable

The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.

Recruiting
NCT05092217Phase 2

Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma

Unknown
NCT04778956Phase 3

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Recruiting
NCT03604601

Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma

Completed
NCT02454647

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9